These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5148882)

  • 21. Control of infection with gram-negative bacteria in patients at special risk.
    Lowbury EJ
    Proc R Soc Med; 1971 Sep; 64(9):986-8. PubMed ID: 5000382
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of Lactobacillus casei-containing ointment on the healing and protection against opportunistic infection of thermal injury wounds in mice.
    Horikawa Y
    Hiroshima J Med Sci; 1986 Mar; 35(1):1-14. PubMed ID: 3091538
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current methods of prevention and treatment of burn infection caused by gram-negative microbes].
    Sologub VK; Iudenich VV; Grishina IA; Morozov SS; Minkova GL
    Sov Med; 1977 Mar; (3):106-10. PubMed ID: 867076
    [No Abstract]   [Full Text] [Related]  

  • 24. Burns.
    Shankar PS
    Q Med Rev; 1984 Oct; 35(4):1-32. PubMed ID: 6443700
    [No Abstract]   [Full Text] [Related]  

  • 25. Burns updated.
    Artz CP
    J Trauma; 1976 Jan; 16(1):2-15. PubMed ID: 1107582
    [No Abstract]   [Full Text] [Related]  

  • 26. Topical antibacterial agents: role in prophylaxis and treatment of bacterial infections.
    Kaye ET
    Curr Clin Top Infect Dis; 2000; 20():43-62. PubMed ID: 10943518
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of oral antibiotic suppression for control of infections in patients with thermal injuries.
    Jarrett F; Balish E; Moylan JA
    J Surg Res; 1978 Apr; 24(4):339-42. PubMed ID: 642502
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI
    Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
    Orłowski T; Struzyna J; Badowski A; Schiller B; Kuntze A; Kozaczek W; Goller W
    Wiad Lek; 1980 Nov; 33(21):1697-701. PubMed ID: 6784349
    [No Abstract]   [Full Text] [Related]  

  • 30. Patterns of infection over the past ten years. Topical therapy for infection control.
    Hartford CE
    J Burn Care Rehabil; 1987; 8(1):49-53. PubMed ID: 3646243
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of carbenicillin, gentamicin and vaccines on rats experimentally burned and infected with Pseudomonas aeruginosa.
    Toama MA; Hamed IM; Ashour SM
    Pharmazie; 1980; 35(4):228-30. PubMed ID: 6773076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF; Kharitonova AM; Chanturiia TsK
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The use of aminosides in the burn patient].
    Galizia JP; Besse MD; Goldstein P; Marson JC; Crépy A; Pellerin P
    Cah Anesthesiol; 1986 Oct; 34(6):495-9. PubMed ID: 3801960
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antibacterial effect of preparations for the local treatment of burns and suppurative wounds].
    Kuzin MI; Kolker II; Vares AIu; Fillippovich IuV; Makarenkova RV
    Khirurgiia (Mosk); 1987 Jan; (1):14-8. PubMed ID: 3550249
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti-Pseudomonas immunoglobulin. IV. Combined anti-Pseudomonas immunoglobulin and Pseudomonas vaccine immunotherapy of burned patients--clinical investigations.
    Sakiel S; Schiller B; Buchowicz I; Lysakowska E; Tomanek E; Kruczałowa M; Przewdziecka M
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):523-8. PubMed ID: 6534319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ways of increasing the effectiveness of antibacterial drugs in the treatment of pseudomonas infection in burns].
    Moroz AF; Vinogradova OI; Bekbergenov BM; Brodinova NS; Antsiferova NG
    Khirurgiia (Mosk); 1976 Jun; (6):81-8. PubMed ID: 827653
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibacterial agents for wounds and burns in the developing world. Report on a workshop.
    Ryan TJ
    J Trop Med Hyg; 1992 Dec; 95(6):397-403. PubMed ID: 1460699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of Pseudomonas aeruginosa septicemia in burns].
    Wang DW
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1987 Sep; 3(3):181-3, 237-8. PubMed ID: 3151607
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiences in the use of Kasugamycin for 3rd degree burns infected by Pseudomonas aeruginosa].
    Nakai Y; Asada Y; Sofue M; Shiozaki H
    J Antibiot B; 1967 Jun; 20(3):191-3. PubMed ID: 4965584
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.